scholarly journals Drinking, Alcohol Use Disorder, and Treatment Access and Utilization Among U.S. Racial/Ethnic Groups

2016 ◽  
Vol 41 (1) ◽  
pp. 6-19 ◽  
Author(s):  
Patrice A. C. Vaeth ◽  
Meme Wang-Schweig ◽  
Raul Caetano
1982 ◽  
Vol 43 (11) ◽  
pp. 1259-1262 ◽  
Author(s):  
S Y Schwitters ◽  
R C Johnson ◽  
G E McClearn ◽  
J R Wilson

2016 ◽  
Vol 67 (3) ◽  
pp. 258-258 ◽  
Author(s):  
Mark S. Kaplan ◽  
Nathalie Huguet ◽  
Bentson H. McFarland ◽  
Raul Caetano ◽  
Kenneth R. Conner ◽  
...  

2017 ◽  
Vol 26 (5) ◽  
pp. 422-423 ◽  
Author(s):  
Karen G. Chartier ◽  
Michie N. Hesselbrock ◽  
Victor M. Hesselbrock

2019 ◽  
Vol 29 (Supplement_4) ◽  
Author(s):  
T Barré ◽  
F Marcellin ◽  
V Di Beo ◽  
J Delorme ◽  
P Mathurin ◽  
...  

Abstract Aims Although people who inject drugs (PWID) are the core at-risk population in the hepatitis C (HCV) epidemic in industrialized countries, few initiate treatment. Alcohol use disorder (AUD), common within this population, has been identified as a barrier to HCV treatment uptake in the general population. We investigated whether the arrival of new and well-tolerated HCV treatments (direct-acting antivirals: DAA) has improved HCV treatment uptake in French PWID compared with former treatments (pegylated interferon-based treatments: Peg-IFN). Methods Analyses were based on exhaustive care delivery data collected between 2012 and 2016 (study period) in the French national healthcare reimbursement database. Chronic HCV-infected individuals who received opioid agonist therapy (OAT) at least once during the study period were included. Separate analyses were performed for 2012-2013 (Peg-IFN era, 19,700 patients) and 2014-2016 (DAA era, 22,545 patients). Using discrete-time Cox proportional hazards models, we tested for associations between AUD (i.e. AUD-related long-term illness status, diagnosis coding during hospitalization or AUD pharmacological treatment) and first HCV treatment delivery, after adjusting for gender, age, complementary universal health cover, liver disease severity and type of OAT received. Results Incidence rate of HCV treatment uptake per 100 person-years [95% confidence interval] was 6.56 [6.30-6.84] and 5.70 [5.51-5.89], for Peg-IFN-based treatment (2012-2013) and DAA (2014-2016), respectively. After multiple adjustment, people with AUD not receiving related medication had 30% and 14% lower Peg-IFN-based treatment and DAA uptake, respectively, than those without AUD (hazard ratio [95%CI]: 0.70 [0.62-0.80] and 0.86 [0.78-0.94]). No difference was observed between those treated for AUD and those without AUD. Conclusions Despite the benefits of DAA, untreated AUD is still a major barrier to HCV treatment access for PWID in France. Key messages AUD is still a barrier to HCV treatment for French PWID. DAA availability improved HCV treatment uptake for PWID with AUD.


2020 ◽  
Vol 7 (4) ◽  
pp. 1-9
Author(s):  
Collins E Lewis ◽  

Alcohol use disorder is a chronic disease, and the consumption of alcohol after treatment is an integral part of the disease process. However, drinking alcohol itself is not a disorder; persistent problematic drinking is. This paper assesses the stability of the yearly drinking patterns of individuals with alcohol use disorder after discharge from psychiatric hospitalization for Alcohol Use Disorder (AUD).


2018 ◽  
Vol 1 (1) ◽  
pp. 18-33
Author(s):  
Euchay Ngozi Horsman

This study examined whether and how underage drinking (UD) relates with concomitant alcohol use disorder and poor educational attainment (CAUDAPEA). A total of 39,860 participants (25-75 years old), roughly 59% of the 2010 National Survey of Drug Use and Health (NSDUH) sample, were drawn for the study. Correlation and regression analyses were used to address the research question. Demographic characteristics of respondents were analyzed using t-test or Chi-square statistics. Alpha was set at .05 to determine statistical significance. Underage drinking alone was a strong and statistically significant predictor of CAUDAPEA. The simple binary logistic regression model identified was statistically significant: (chi-square = 24.19, df =1, p < .05), (Cox and Snell R2 = 0.001), and (Nagelkerke R2 = 0.015), which suggests that using the Nagelkerke R2, the model explains roughly 1.5% of the variation in CAUDAPEA. The regression coefficient and the Wald statistic show that the effect of having underage drinking history (UDHISTORY) on CAUDAPEA is highly significant (Wald F = 14.44, df = 1, p < .05) with odds ratio = 4.86 indicating that currently legal age drinkers with UDHISTORY were about five times more likely to experience CAUDAPEA than their counterparts without UDHISTORY. When demographic variables (age, gender, race/ethnicity) were added to the model, the identified final multiple logistic regression model was statistically significant, (chi-square = 132.33, df = 10, p < .05), (Cox and Snell R2 = 0.008), and (Nagelkerke R2 = 0.079) which suggests that using the Nagelkerke R2, the model explains roughly 7.9% of the variance in CAUDAPEA, an improvement over the model with UDHISTORY alone. Results suggest different ways of looking at relationships between underage drinking, alcohol use disorder, and educational attainment. Implications for rehabilitation and prevention are discussed.   Keywords: underage drinking, alcohol use disorder, poor educational attainment, concomitance


Sign in / Sign up

Export Citation Format

Share Document